BioAdvance News

BioAdvance Announces ~$7M in Recent Investments and Leadership Transition

By WebmasterSeptember 29, 2021November 1st, 2024No Comments

BioAdvance Announces ~$7M in Recent Investments and Leadership Transition

Barbara Schilberg retiring as Managing Director and CEO;

Shahram Hejazi, Ph.D., appointed as Managing Director and CEO

Previous PostHalo Labs Launches the Aura GT™ for Gene Therapy Product Quality
Next PostRenovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science